Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8586706 | Clinical Nutrition | 2018 | 33 Pages |
Abstract
A specified oral vitamin D regimen successfully and safely achieved target or near-target levels, improved symptom-based activity scores, but did not alter objective measures of intestinal or systemic inflammation. A modified version of this dose-escalating regimen would be suitable for a randomised placebo-controlled trial, but does require regular safety monitoring.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Critical Care and Intensive Care Medicine
Authors
Mayur Garg, Ourania Rosella, Gennaro Rosella, Yunqiu Wu, John S. Lubel, Peter R. Gibson,